Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Where SEI Investments Stands With Analysts

Analysts have provided the following ratings for SEI Investments (NASDAQ:SEIC) within the last quarter:

Benzinga

Earnings Preview: First Hawaiian

First Hawaiian (NASDAQ:FHB) is set to give its latest quarterly earnings report on Friday, 2022-04-22. Here's what investors need to know before the announcement. Analysts estimate that First Hawaiian will report an earnings per share (EPS) of $0.42.

Benzinga

Ominous Death Cross Forms On Qualcomm's Chart

If history is any guide, there may be trouble ahead for shares of Qualcomm (NASDAQ:QCOM). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

A Bearish Sign Appears On NVIDIA's Chart

If history is any guide, there may be trouble ahead for shares of NVIDIA (NASDAQ:NVDA). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Overview Of Value Stocks In The Financial Services Sector

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

This Foreboding Sign Looms Over Datadog's Chart

If history is any guide, there may be trouble ahead for shares of Datadog (NASDAQ:DDOG). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

A Bearish Sign Appears On Biomarin Pharmaceutical's Chart

If history is any guide, there may be trouble ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Prospect Capital: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Prospect Capital (NASDAQ:PSEC).

Benzinga

Krispy Kreme: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Krispy Kreme (NASDAQ:DNUT).

Benzinga

Amazon, SpaceX And Others Win $279M In NASA Contracts

Amazon.com Inc's (NASDAQ:AMZN) satellite venture, Tesla Inc (NASDAQ:TSLA) CEO Elon Musk-led SpaceX's Starlink network, and other satellite firms won a combined $278.5 million in contracts from NASA to demonstrate communications in space. Amazon's Project Kuiper, a planned network of over 3,000 satellites built to beam broadband internet to remote regions, won $67 million, Reuters reports. SpaceX's…

Benzinga

EXCLUSIVE: Why Canopy Growth's CEO Says US Cannabis Industry Can Reach 'Same Size As The Beer Industry'

Canopy Growth Corp (NASDAQ: CGC) and Wana Brands are positioning themselves to be U.S.

Benzinga

Monday Is Your Last Chance To Buy Cal-Maine Foods Before The Dividend Payout

Monday marks the last chance for investors to receive the next dividend payout from Cal-Maine Foods (NASDAQ:CALM).

Benzinga

Fastenal: Dividend Insights

Monday marks the last chance for investors to receive the next dividend payout from Fastenal (NASDAQ:FAST).

Benzinga

Lexaria Posied To Receive US Patent For DehydraTECH To Deliver Antiviral Drugs

Lexaria Bioscience Corp (NASDAQ:LEXX) is receiving its first-ever patent for DehydraTECH technology in the enhanced delivery of antiviral drugs. Lexaria has received notification from the United States Patent and Trademark Office that patent 11,311,559 for Compositions and Methods For Enhanced Delivery Of Antiviral Agents will be issued to the Company on April 26. "This…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Where FTC Solar Stands With Analysts

Over the past 3 months, 4 analysts have published their opinion on FTC Solar (NASDAQ:FTCI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

If You Invested $100 In AstraZeneca 5 Years Ago, Here's How Much You Would Have Today

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 4.24% on an annualized basis producing an average annual return of 17.72%. Currently, AstraZeneca has a market capitalization of $213.61 billion.

Benzinga

Gentex Earnings Preview

Gentex (NASDAQ:GNTX) is set to give its latest quarterly earnings report on Friday, 2022-04-22. Here's what investors need to know before the announcement. Analysts estimate that Gentex will report an earnings per share (EPS) of $0.32.

Benzinga

The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What 4 Analyst Ratings Have To Say About Intra-Cellular Therapies

Analysts have provided the following ratings for Intra-Cellular Therapies (NASDAQ:ITCI) within the last quarter:

Benzinga

Tilray's Breckenridge Distillery Wins Two Double Gold And One Gold Medal At The San Francisco World Spirits Competition

Breckenridge Distillery, subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), celebrates two Double Gold and one Gold medal at the 2022 San Francisco World Spirits Competition.

Benzinga

Analyzing United Airlines Holdings Inc's Short Interest

United Airlines Holdings Inc's (NASDAQ:UAL) short percent of float has risen 48.46% since its last report. The company recently reported that it has 20.21 million shares sold short, which is 6.25% of all regular shares that are available for trading.

Benzinga

Je Cleantech Holdings Limited To Start Trading Tomorrow

JE Cleantech Holdings Limited (NASDAQ:JCSE) IPO will take place April, 22 on the NASDAQ exchange under the ticker JCSE. The company is offering shares at an expected price of $4.00 per share with an insider lock-up period of 180 days ending on October 19, 2022.

Benzinga

Expert Ratings for Aptinyx

Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings:

Benzinga

Recap: Heartland Express Q1 Earnings

Heartland Express (NASDAQ:HTLD) reported its Q1 earnings results on Thursday, April 21, 2022 at 09:00 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: City Holding Q1 Earnings

City Holding (NASDAQ:CHCO) reported its Q1 earnings results on Thursday, April 21, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

1 … 707 708 709 710

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.